Complex Cardiovascular Cases: Novel Treatment Strategies for High Risk Patients

Credit Area      

Release Date: Feb 8, 2012          Expiration Date: Feb 8, 2013



Program Overview


This program will examine several seemingly unrelated, complicated disease states and explore common underlying pathologic features that confer increased risk of major adverse cardiovascular events. Diseases such as complex dyslipidemia, diabetes mellitus, and chronic kidney disease all commonly lead to adverse clinical events that reflect underlying cardiovascular disease. As such, this webcourse describes the inter-relationships of pathologic processes that converge and manifest as cardiovascular risk elements.

Complex Cardiovascular Cases will inform physicians about the latest clinical data and new therapeutic insights regarding treatment options to reduce the risk of major adverse cardiac events in patients with a variety of complex disease states. It will also provide physicians with the latest informed thinking about how to incorporate new therapeutic insights into clinical practice, in order to reduce risk of major adverse cardiovascular events in their at-risk patients.


Cases presented by:

DANA SIMPLER, MD
Primary Care Practitioner, Internal Medicine
Mercy Medical Center
Baltimore, MD

Dr. Simpler deals with complex cardiovascular cases on a daily basis as an internist at Mercy Medical Center in Baltimore, MD.


Faculty


MICHAEL H. DAVIDSON, MD, FACC, FACP, FNLA (Chair)
Clinical Professor
Director of Preventive Cardiology
The University of Chicago Pritzker School of Medicine
Chicago, IL
Read Biography

GEORGE BAKRIS, MD, DMSc (Hon.), FASH, FASN
Professor of Medicine
Director, Hypertensive Diseases Unit
The University of Chicago Pritzker School of Medicine
Chicago, IL
Read Biography

MATTHEW R. WEIR, MD
Professor and Director
Division of Nephrology
University of Maryland School of Medicine
Baltimore, MD
Read Biography


Target Audience


This activity is intended for cardiologists and other physicians who manage patients with complex cardiovascular risk.

Educational Objectives


This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.

At the conclusion of this activity, participants should be able to demonstrate improved ability to:

  • Examine the relative effectiveness of intensive statin treatment and existing HDL raising therapies to reduce CVD risk in dyslipidemic patients
  • Explain the clinical data that illustrate the effectiveness of renin system modulation and lipoprotein management to reduce CVD risk in patients with chronic kidney disease
  • Discuss the complexities of reducing CVD risk in patients with diabetes mellitus
  • Incorporate multifaceted CVD risk factor reduction strategies into the management of patients with complicated health issues that put them at risk of major adverse cardiovascular events

Accreditation


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Potomac Center for Medical Education and Rockpointe Corporation. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.


Designation Statement


The Potomac Center for Medical Education designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit, the post-test, or evaluation, please email contact@potomacme.org.


Disclosure Information


The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program sponsored by the Potomac Center for Medical Education are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Michael H. Davidson, MD, FACC, FACP, FNLA: Advisory Board/Consultant:: Amgen, Merck & Co., Roche, Sanofi-Aventis; Board of Directors/Equity: Omthera Pharmaceuticals

George Bakris, MD, DMSc (Hon.), FASH, FASN: Research Support:: Forest Labs, Novartis; Principal Investigator: Medtronic, Relapysa; Consultant: Abbott, CVRx, Eli Lilly, Food and Drug Administration, Johnson & Johnson, Servier, Takeda; Speakers Bureau: Novartis, Takeda

Matthew R. Weir, MD: Scientific Consultant: Merck & Co., Novartis, Pfizer, Sanofi

Dana Simpler, MD: Nothing to Disclose

Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Barry Watkins, PhD; Bradley Pine; Blair St. Amand; Jay Katz; Laurie Frueh, MD: Nothing to Disclose


FDA Disclosure


The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.


System Requirements


In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.


Instructions for Participants and Obtaining CME Credit


There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test and evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 1.5 hours. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test.


Jointly Sponsored By


This activity is jointly sponsored by  and    and co-sponsored by the American College of Cardiology Foundation.

Supported By


Supported by an independent educational grant from

 


By clicking the View/Register Button you are agreeing that you have read and understood the information on this page.